AU Patent

AU2013354979A1 — Administering compositions comprising docosapentaenoic acid

Assigned to Matinas Biopharma Inc · Expires 2015-06-11 · 11y expired

What this patent protects

The present invention relates to methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (LDL) cholesterol, non-HDL cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.

USPTO Abstract

The present invention relates to methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (LDL) cholesterol, non-HDL cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013354979A1
Jurisdiction
AU
Classification
—
Expires
2015-06-11
Drug substance claim
No
Drug product claim
No
Assignee
Matinas Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.